What sulfur-producing bacteria reside in the gastrointestinal (GI) tract?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Sulfur-producing bacteria in the GI tract Certain sulfur-producing bacteria, such as Desulfovibrio 1, have been found to reside in the human gut.

Key Characteristics of these Bacteria

  • These bacteria are known to produce hydrogen sulfide gas as a byproduct of their metabolism, which can have both beneficial and harmful effects on the host.
  • Desulfovibrio species, for example, are sulfate-reducing bacteria that can contribute to the production of hydrogen sulfide in the gut 1.

Importance of Balance in the Gut Microbiome

  • It is essential to note that an overgrowth of these bacteria can lead to an imbalance in the gut microbiome, potentially causing gastrointestinal symptoms.
  • Maintaining a balanced gut microbiome through a healthy diet and lifestyle is crucial to preventing an overgrowth of sulfur-producing bacteria.

Key Points to Consider

  • The production of hydrogen sulfide by Desulfovibrio has been linked to increased intestinal permeability and potentially carcinogenic effects 1.
  • A healthy balance of the gut microbiome is necessary to prevent the overgrowth of sulfur-producing bacteria and maintain overall gut health.

From the Research

Sulfur-Producing Bacteria in the GI Tract

  • The human intestinal bacterium Bilophila wadsworthia is a key source of hydrogen sulfide (H2S) production in the gut, as identified in a study published in 2019 2.
  • Desulfovibrio species, such as Desulfovibrio desulfuricans and Desulfovibrio alaskensis, are also sulfur-producing bacteria that reside in the GI tract, with a unique glycyl radical enzyme (GRE) enabling their energy metabolism 2.
  • Other sulfidogenic bacteria, including Escherichia, may also contribute to H2S production in the gut, particularly in the context of inflammatory bowel diseases (IBD) 3.

Mechanisms of Sulfur Production

  • The taurine desulfonation pathway in Bilophila wadsworthia involves the reduction of sulfoacetaldehyde to isethionate, which is then cleaved to sulfite and acetaldehyde by a GRE, ultimately leading to H2S production 2.
  • Sulfate-reducing bacteria, such as Desulfovibrio species, use molecular hydrogen and lactate as electron donors and sulfate as the terminal electron acceptor to produce H2S 4.
  • The enzymatic desulfhydration of cysteine by heterotrophic bacteria also contributes to H2S production in the gut 4.

Implications for Human Health

  • The overgrowth of sulfidogenic bacteria, including Bilophila wadsworthia and Desulfovibrio species, has been linked to various diseases, including inflammatory bowel diseases and colorectal cancer 3, 5, 6.
  • High concentrations of H2S produced by these bacteria can disrupt the integrity of the intestinal epithelium and mucus barrier, triggering inflammation and contributing to disease pathology 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A glycyl radical enzyme enables hydrogen sulfide production by the human intestinal bacterium Bilophila wadsworthia.

Proceedings of the National Academy of Sciences of the United States of America, 2019

Research

The role of fecal sulfur metabolome in inflammatory bowel diseases.

International journal of medical microbiology : IJMM, 2021

Research

Sulfur Cycling and the Intestinal Microbiome.

Digestive diseases and sciences, 2017

Research

Role of sulfidogenic members of the gut microbiota in human disease.

Advances in microbial physiology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.